Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT05471505
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with atrial fibrillation (AF) anytime in the baseline period or on the index date, also have definitive diagnosis of AF anytime in the baseline period, on the index date, or post-index period.
* Prescribed apixaban or warfarin on or after the day of AF diagnosis. The first observed prescription will be used to identify the patient's index date and treatment cohort
* No use of the any oral anticoagulants (OACs) during the baseline period (the 180 days before the index date)
* Age of 18 years or older on the index date
Exclusion Criteria:
* Having a diagnosis of valvular atrial fibrillation, post-operative atrial fibrillation, rheumatic atrial fibrillation or mechanical-valvular atrial fibrillation during the baseline and post-index period
* Having a procedure of prosthetic heart valve during the baseline period
* Having a cardiac surgery procedure record during the baseline period
* Having a diagnosis of venous thromboembolism during the baseline period
* Having a hemodialysis during the baseline period
* Female patients with pregnancy during the baseline and follow-up period
* Patients prescribed apixaban other than approved daily dose (\<5 mg or \>10 mg)
* Patients prescribed OACs during baseline period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05471505
Study Brief:
Protocol Section:
NCT05471505